General description
Asparaginase is an antineoplastic enzyme, used in the treatment of acute lymphoblastic leukaemia.
ATC codes
Medicine type
Biological agent
EML status history
First added in 1993
(TRS
850)
for
Unspecified malignant neoplasms of unspecified sites
Removed in 2015
(TRS
994)
for
Unspecified malignant neoplasms of unspecified sites
Added in 2015
(TRS
994)
for
Lymphoid leukaemia, not elsewhere classified
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Powder for injection: 10 000 IU in vial.
- Parenteral > General injections > unspecified: 10000 IU in vial powder for injection